Genprex, Inc. (GNPX): Nasdaq/NYSE listing notice — Genprex faces Nasdaq delisting for both equity and bid price non-compliance; hearing requested

Genprex, Inc.

Stockholders' equity of $1.39M as of June 30, 2025, below Nasdaq's $2.5M minimum requirement.
Also non-compliant with $1.00 bid price rule; previous delisting determination from Aug 12, 2025.
Company requested a hearing on Aug 19, 2025, which stays delisting pending Panel decision.
No assurance that Panel will grant continued listing or extension.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Genprex, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

August 19, 2025, Genprex, Inc. (“Genprex” or the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market, under Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Requirement”), because the Company’s stockholders’ equity of $1,391,195 as reported in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2025 was below the required minimum of $2.5 millio

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Genprex, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-027451

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.